Japan's Takeda Pharmaceutical said on Thursday its experimental pill for a type of skin disease, developed using artificial ...

Researchers in China report that global incidence rates of psoriasis rose slightly from 1990 to 2021 and are projected to continue rising for both men and women through 2050. Psoriasis is a chronic ...

Andy Dinsdale began walking the southern English coast in search of a “sea heart,” a tough Mahogany seed carried by ocean currents from Central and South American rainforests. In his quest to find one ...

Icotrokinra, a targeted oral peptide that selectively binds the interleukin-23 receptor, is under investigation for the treatment of plaque psoriasis. We conducted a phase 3, double-blind, randomized, ...

Oil majors, including Shell, BP, and TotalEnergies, are scaling back or delaying biofuel projects despite earlier commitments to ramp up production. Shell’s decision to cancel its massive Rotterdam ...

Injecting bio-oil made from corn stalks and forest debris into the deep shafts of abandoned crude oil wells could be a viable form of carbon sequestration, a new Iowa State University study found.

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min More than two dozen restaurants ...

Livzon Mabpharm Inc.’s anti-IL-17A/F monoclonal antibody, LZM-012, met the primary endpoint in a phase III trial in moderate to severe plaque psoriasis. Conducted at Fudan University’s Huashan ...

Until about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an idea of how much the field has changed, clinical guidelines on psoriasis ...

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to ...

Ustekinumab offers superior itch relief compared to guselkumab in severe psoriasis, despite guselkumab's better skin lesion improvement. The study involved 108 patients, with 90.4% of ...